Neurochemical Research

, Volume 37, Issue 8, pp 1681–1689 | Cite as

Brain Region-Specific Glutathione Redox Imbalance in Autism

  • Abha Chauhan
  • Tapan Audhya
  • Ved Chauhan
Original Paper


Autism is a heterogeneous, behaviorally defined neurodevelopmental disorder. Recently, we reported a brain region–specific increase in lipid peroxidation, and deficits in mitochondrial electron transport chain complexes in autism, suggesting the role of oxidative stress and mitochondrial dysfunction in the pathophysiology of autism. However, the antioxidant status of the brain is not known in autism. Glutathione is a major endogenous antioxidant that plays a crucial role in protecting cells from exogenous and endogenous toxins, particularly in the central nervous system. The present study examines the concentrations of glutathione (GSH, reduced form; and GSSG, oxidized form) and the redox ratio of GSH to GSSG (marker of oxidative stress) in different regions of brains from autistic subjects and age-matched control subjects. In the cerebellum and temporal cortex from subjects with autism, GSH levels were significantly decreased by 34.2 and 44.6 %, with a concomitant increase in the levels of GSSG by 38.2 and 45.5 %, respectively, as compared to the control group. There was also a significant decrease in the levels of total GSH (tGSH) by 32.9 % in the cerebellum, and by 43.1 % in the temporal cortex of subjects with autism. In contrast, there was no significant change in GSH, GSSG and tGSH levels in the frontal, parietal and occipital cortices in autism versus control group. The redox ratio of GSH to GSSG was also significantly decreased by 52.8 % in the cerebellum and by 60.8 % in the temporal cortex of subjects with autism, suggesting glutathione redox imbalance in the brain of individuals with autism. These findings indicate that autism is associated with deficits in glutathione antioxidant defense in selective regions of the brain. We suggest that disturbances in brain glutathione homeostasis may contribute to oxidative stress, immune dysfunction and apoptosis, particularly in the cerebellum and temporal lobe, and may lead to neurodevelopmental abnormalities in autism.


Autism Brain Glutathione Neurodevelopment Oxidative stress Redox 



Human brain tissues were obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD. This work was supported by funds from the Department of Defense Autism Spectrum Disorders Research Program AS073224P2, the Autism Research Institute and the NYS Office for People with Developmental Disabilities.


  1. 1.
    Lord C, Cook EH, Leventhal BL, Amaral DG (2000) Autism spectrum disorders. Neuron 28:355–363PubMedCrossRefGoogle Scholar
  2. 2.
    Rice C (2009) Prevalence of autism spectrum disorders—Autism and developmental disabilities monitoring network, United States, 2006. MMWR Surveill Summ 58:1–20Google Scholar
  3. 3.
    Chauhan A, Chauhan V, Brown WT (eds) (2009) Autism: Oxidative stress, inflammation and immune abnormalities. CRC Press, Taylor and Francis Group, FloridaGoogle Scholar
  4. 4.
    Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M (2008) How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicology 29:190–201PubMedCrossRefGoogle Scholar
  5. 5.
    Chauhan A, Chauhan V (2006) Oxidative stress in autism. Pathophysiology 13:171–181PubMedCrossRefGoogle Scholar
  6. 6.
    Kern JK, Jones AM (2006) Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9:485–499PubMedCrossRefGoogle Scholar
  7. 7.
    Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de WJ (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40–45PubMedCrossRefGoogle Scholar
  8. 8.
    Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M (2009) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207:111–116PubMedCrossRefGoogle Scholar
  9. 9.
    Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67–81PubMedCrossRefGoogle Scholar
  10. 10.
    Juurlink BH, Paterson PG (1998) Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21:309–334PubMedGoogle Scholar
  11. 11.
    Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–671PubMedCrossRefGoogle Scholar
  12. 12.
    Perry SW, Norman JP, Litzburg A, Gelbard HA (2004) Antioxidants are required during the early critical period, but not later, for neuronal survival. J Neurosci Res 78:485–492PubMedCrossRefGoogle Scholar
  13. 13.
    Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390:191–214PubMedCrossRefGoogle Scholar
  14. 14.
    Circu ML, Aw TY (2008) Glutathione and apoptosis. Free Radic Res 42:689–706PubMedCrossRefGoogle Scholar
  15. 15.
    Franco R, Cidlowski JA (2009) Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 16:1303–1314PubMedCrossRefGoogle Scholar
  16. 16.
    Ghezzi P (2011) Role of glutathione in immunity and inflammation in the lung. Int J Gen Med 4:105–113PubMedGoogle Scholar
  17. 17.
    Haddad JJ, Harb HL (2005) L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol Immunol 42:987–1014PubMedCrossRefGoogle Scholar
  18. 18.
    Martin HL, Teismann P (2009) Glutathione—a review on its role and significance in Parkinson’s disease. FASEB J 23:3263–3272PubMedCrossRefGoogle Scholar
  19. 19.
    Kolevzon A, Gross R, Reichenberg A (2007) Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med 161:326–333PubMedCrossRefGoogle Scholar
  20. 20.
    Kinney DK, Munir KM, Crowley DJ, Miller AM (2008) Prenatal stress and risk for autism. Neurosci Biobehav Rev 32:1519–1532PubMedCrossRefGoogle Scholar
  21. 21.
    Miller MT, Stromland K, Ventura L, Johansson M, Bandim JM, Gillberg C (2005) Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int J Dev Neurosci 23:201–219PubMedCrossRefGoogle Scholar
  22. 22.
    Ono H, Sakamoto A, Sakura N (2001) Plasma total glutathione concentrations in healthy pediatric and adult subjects. Clin Chim Acta 312:227–229PubMedCrossRefGoogle Scholar
  23. 23.
    Erden-Inal M, Sunal E, Kanbak G (2002) Age-related changes in the glutathione redox system. Cell Biochem Funct 20:61–66PubMedCrossRefGoogle Scholar
  24. 24.
    Akerboom TP, Bilzer M, Sies H (1982) The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J Biol Chem 257:4248–4252PubMedGoogle Scholar
  25. 25.
    Slivka A, Spina MB, Cohen G (1987) Reduced and oxidized glutathione in human and monkey brain. Neurosci Lett 74:112–118PubMedCrossRefGoogle Scholar
  26. 26.
    Chauhan A, Chauhan V, Brown WT, Cohen I (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin—the antioxidant proteins. Life Sci 75:2539–2549PubMedCrossRefGoogle Scholar
  27. 27.
    Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O, Meram I (2004) Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254:143–147PubMedGoogle Scholar
  28. 28.
    Meguid NA, Dardir AA, Abdel-Raouf ER, Hashish A (2011) Evaluation of oxidative otress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res 143:58–65PubMedCrossRefGoogle Scholar
  29. 29.
    Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC (2005) Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 73:379–384PubMedCrossRefGoogle Scholar
  30. 30.
    Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V (2011) Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 117:209–220PubMedCrossRefGoogle Scholar
  31. 31.
    Chauhan A, Chauhan V (2012) Brain oxidative stress and mitochondrial abnormalities in autism. In: Fatemi SH et al. Consensus paper: pathological role of cerebellum in autism. Cerebellum. doi: 10.007/s12311-012-0355-9
  32. 32.
    López-Hurtado E, Prieto JJ (2008) A microscopic study of language-related cortex in autism. Am J Biochem Biotech 4:130–145CrossRefGoogle Scholar
  33. 33.
    Evans TA, Siedlak SL, Lu L, Fu X, Wang Z, McGinnis WR, Fakhoury E, Castellani RJ, Hazen SL, Walsh WJ, Lewis AT, Salomon RG, Smith MA, Perry G, Zhu X (2008) The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am J Biochem Biotech 4:61–72CrossRefGoogle Scholar
  34. 34.
    Sajdel-Sulkowska EM, Xu M, Koibuchi N (2009) Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 8:366–372PubMedCrossRefGoogle Scholar
  35. 35.
    Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T (2002) Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67:341–343PubMedCrossRefGoogle Scholar
  36. 36.
    Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011) Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr 11:111PubMedCrossRefGoogle Scholar
  37. 37.
    Al Gadani Y, El Ansary A, Attas O, Al Ayadhi L (2009) Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem 42:1032–1040PubMedCrossRefGoogle Scholar
  38. 38.
    Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR (2009) A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 34:386–393PubMedCrossRefGoogle Scholar
  39. 39.
    Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) 8:34CrossRefGoogle Scholar
  40. 40.
    James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141B:947–956PubMedCrossRefGoogle Scholar
  41. 41.
    Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222–230PubMedCrossRefGoogle Scholar
  42. 42.
    Lenaz G (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52:159–164PubMedCrossRefGoogle Scholar
  43. 43.
    Santori G, Domenicotti C, Bellocchio A, Pronzato MA, Marinari UM, Cottalasso D (1997) Different efficacy of iodoacetic acid and N-ethylmaleimide in high-performance liquid chromatographic measurement of liver glutathione. J Chromatogr B Biomed Sci Appl 695:427–433PubMedCrossRefGoogle Scholar
  44. 44.
    Loughlin AF, Skiles GL, Alberts DW, Schaefer WH (2001) An ion exchange liquid chromatography/mass spectrometry method for the determination of reduced and oxidized glutathione and glutathione conjugates in hepatocytes. J Pharm Biomed Anal 26:131–142PubMedCrossRefGoogle Scholar
  45. 45.
    Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, Tosic M, Werge T, Cuenod M, Do KQ (2007) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA 104:16621–16626PubMedCrossRefGoogle Scholar
  46. 46.
    Yao JK, Leonard S, Reddy R (2006) Altered glutathione redox state in schizophrenia. Dis Markers 22:83–93PubMedGoogle Scholar
  47. 47.
    Andreazza AC, Kauer-Sant’Anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111:135–144PubMedCrossRefGoogle Scholar
  48. 48.
    Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, Ribera JM, Villar AM (2008) Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer’s disease from mild cognitive impairment. Free Radic Res 42:162–170PubMedCrossRefGoogle Scholar
  49. 49.
    Aoyama K, Watabe M, Nakaki T (2008) Regulation of neuronal glutathione synthesis. J Pharmacol Sci 108:227–238PubMedCrossRefGoogle Scholar
  50. 50.
    Haas RH (2010) Autism and mitochondrial disease. Dev Disabil Res Rev 16:144–153PubMedCrossRefGoogle Scholar
  51. 51.
    Rossignol DA, Frye RE (2011) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17:290–314PubMedCrossRefGoogle Scholar
  52. 52.
    Mari M, Morales A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11:2685–2700PubMedCrossRefGoogle Scholar
  53. 53.
    Ayer A, Tan SX, Grant CM, Meyer AJ, Dawes IW, Perrone GG (2010) The critical role of glutathione in maintenance of the mitochondrial genome. Free Radic Biol Med 49:1956–1968PubMedCrossRefGoogle Scholar
  54. 54.
    Ji L, Chauhan A, Brown WT, Chauhan V (2009) Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. Life Sci 85:788–793PubMedCrossRefGoogle Scholar
  55. 55.
    Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJ, Perstin J, Preston TJ, Wiley MJ, Wong AW (2009) Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 108:4–18PubMedCrossRefGoogle Scholar
  56. 56.
    Wells PG, Bhuller Y, Chen CS, Jeng W, Kasapinovic S, Kennedy JC, Kim PM, Laposa RR, McCallum GP, Nicol CJ, Parman T, Wiley MJ, Wong AW (2005) Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol 207:354–366PubMedCrossRefGoogle Scholar
  57. 57.
    Hitchler MJ, Domann FE (2007) An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 43:1023–1036PubMedCrossRefGoogle Scholar
  58. 58.
    Whitney ER, Kemper TL, Bauman ML, Rosene DL, Blatt GJ (2008) Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum 7:406–416PubMedCrossRefGoogle Scholar
  59. 59.
    Casanova MF (2007) The neuropathology of autism. Brain Pathol 17:422–433PubMedCrossRefGoogle Scholar
  60. 60.
    Kern JK (2003) Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 25:377–382PubMedCrossRefGoogle Scholar
  61. 61.
    Araghi-Niknam M, Fatemi SH (2003) Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol Neurobiol 23:945–952PubMedCrossRefGoogle Scholar
  62. 62.
    Goines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L, Hansen R, Hertz-Picciotto I, Ashwood P, Van de WJ (2011) Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun 25:514–523PubMedCrossRefGoogle Scholar
  63. 63.
    Hetzler BE, Griffin JL (1981) Infantile autism and the temporal lobe of the brain. J Autism Dev Disord 11:317–330PubMedCrossRefGoogle Scholar
  64. 64.
    Zilbovicius M, Boddaert N, Belin P, Poline JB, Remy P, Mangin JF, Thivard L, Barthelemy C, Samson Y (2000) Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. Am J Psychiatry 157:1988–1993PubMedCrossRefGoogle Scholar
  65. 65.
    Bigler ED, Mortensen S, Neeley ES, Ozonoff S, Krasny L, Johnson M, Lu J, Provencal SL, McMahon W, Lainhart JE (2007) Superior temporal gyrus, language function, and autism. Dev Neuropsychol 31:217–238PubMedCrossRefGoogle Scholar
  66. 66.
    Gage NM, Juranek J, Filipek PA, Osann K, Flodman P, Isenberg AL, Spence MA (2009) Rightward hemispheric asymmetries in auditory language cortex in children with autistic disorder: an MRI investigation. J Neurodev Disord 1:205–214PubMedCrossRefGoogle Scholar
  67. 67.
    Jou RJ, Minshew NJ, Keshavan MS, Vitale MP, Hardan AY (2010) Enlarged right superior temporal gyrus in children and adolescents with autism. Brain Res 1360:205–212PubMedCrossRefGoogle Scholar
  68. 68.
    Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30:303–311PubMedCrossRefGoogle Scholar
  69. 69.
    van Kooten IA, Palmen SJ, von Cappeln P, Steinbusch HW, Korr H, Heinsen H, Hof PR, van Engeland H, Schmitz C (2008) Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 131:987–999PubMedCrossRefGoogle Scholar
  70. 70.
    Bolte S, Hubl D, Feineis-Matthews S, Prvulovic D, Dierks T, Poustka F (2006) Facial affect recognition training in autism: can we animate the fusiform gyrus? Behav Neurosci 120:211–216PubMedCrossRefGoogle Scholar
  71. 71.
    Pierce K, Haist F, Sedaghat F, Courchesne E (2004) The brain response to personally familiar faces in autism: findings of fusiform activity and beyond. Brain 127:2703–2716PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.NYS Institute for Basic Research in Developmental DisabilitiesStaten IslandUSA
  2. 2.New York University School of MedicineNew YorkUSA
  3. 3.Health Diagnostics and Research InstituteSouth AmboyUSA

Personalised recommendations